During the past decade, Research Strategies of Memphis, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 20 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Strategies of Memphis, LLC" #1 sponsor was "Shire" with 5 trials, followed by "Sunovion" with 5 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "ACADIA Pharmaceuticals Inc." with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Strategies of Memphis, LLC" #1 collaborator was "Takeda" with 2 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Research Strategies of Memphis, LLC" are "Major Depressive Disorder" (8 trials), "Depressive Disorder, Major" (6 trials), "Schizophrenia" (6 trials), "Adjunctive Treatment of Major Depressive Disorder" (2 trials) and "Adult Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Research Strategies of Memphis, LLC" in a lesser frequency.

Most popular intervention types in "Research Strategies of Memphis, LLC" are "Drug" (32 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Rapastinel" (4 trials), "Lurasidone HCl" (2 trials), "Pimavanserin" (2 trials) and "Vilazodone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Research Strategies of Memphis, LLC" are 32 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Research Strategies of Memphis, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Research Strategies of Memphis, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Research Strategies of Memphis, LLC, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".